根据美国证券交易委员会(SEC)最新披露的文件,Matinas BioPharma Holdings, Inc(简称Matinas BioPharma)正面临一项重大变故。Btig已正式宣布,将终止与Matinas BioPharma Holdings签署的销售协议。这一决定自2026年7月23日起立即生效,不给公司留下任何缓冲余地。
根据美国证券交易委员会(SEC)最新披露的文件,Matinas BioPharma Holdings, Inc(简称Matinas BioPharma)正面临一项重大变故。Btig已正式宣布,将终止与Matinas BioPharma Holdings签署的销售协议。这一决定自2026年7月23日起立即生效,不给公司留下任何缓冲余地。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.